X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Elder Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ADCOCK INGRAM
Jun-14
ELDER PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs380354-   
Low Rs188255-   
Sales per share (Unadj.) Rs491.2105.2-  
Earnings per share (Unadj.) Rs-3.2-26.5-  
Cash flow per share (Unadj.) Rs14.4-22.0-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.582.6-  
Shares outstanding (eoy) m20.54168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.62.9 20.0%   
Avg P/E ratio x-89.3-11.5 777.4%  
P/CF ratio (eoy) x19.7-13.9 -142.3%  
Price / Book Value ratio x0.83.7 20.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83351,396 11.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2,1793,226 67.6%   
Avg. sales/employee Rs ThNM4,137.7-  
Avg. wages/employee Rs ThNM751.4-  
Avg. net profit/employee Rs ThNM-1,042.6-  
INCOME DATA
Net Sales Rs m10,08917,763 56.8%  
Other income Rs m257124 206.3%   
Total revenues Rs m10,34617,888 57.8%   
Gross profit Rs m-792-3,078 25.7%  
Depreciation Rs m361767 47.1%   
Interest Rs m2,756481 572.8%   
Profit before tax Rs m-3,653-4,202 86.9%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125263 47.7%   
Profit after tax Rs m-65-4,476 1.5%  
Gross profit margin %-7.8-17.3 45.3%  
Effective tax rate %-3.4-6.2 54.8%   
Net profit margin %-0.6-25.2 2.6%  
BALANCE SHEET DATA
Current assets Rs m9,24013,010 71.0%   
Current liabilities Rs m9,9987,320 136.6%   
Net working cap to sales %-7.532.0 -23.4%  
Current ratio x0.91.8 52.0%  
Inventory Days Days46111 41.8%  
Debtors Days Days60124 48.4%  
Net fixed assets Rs m10,1247,584 133.5%   
Share capital Rs m20682 249.4%   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,73413,942 55.5%   
Long term debt Rs m4,8894,900 99.8%   
Total assets Rs m22,88226,338 86.9%  
Interest coverage x-0.3-7.7 4.2%   
Debt to equity ratio x0.60.4 179.9%  
Sales to assets ratio x0.40.7 65.4%   
Return on assets %11.8-15.2 -77.5%  
Return on equity %-0.8-32.1 2.6%  
Return on capital %22.3-19.8 -112.6%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,7541,516 775.2%  
From Investments Rs m-561-466 120.4%  
From Financial Activity Rs m-6,7624,447 -152.1%  
Net Cashflow Rs m4,4325,497 80.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.88 Rs / ZAR

Compare ELDER PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: FDC LTD.  AUROBINDO PHARMA  WOCKHARDT LTD.  FRESENIUS KABI ONCO.  FULFORD INDIA  



Today's Market

Weak Finish to the Week; Realty & Metal Stocks Plunge(Closing)

Indian share markets continued to languish in red in the afternoon session as rupee hit its weakest point since early April amid concerns.

Related Views On News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Rule-Based Investing Can Make A Lot of Money(The 5 Minute Wrapup)

Sep 16, 2017

We take a glimpse of Equitymaster's results from rule based investing.

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS